Allergic conjunctivitis is a kind of eye disease in which it affect the eye surfaces and are commonly associated to immune-mediated inflammatory reactions of these structures. The prevalence of the allergic conjunctivitis is found more in summer and spring across the various regions. Pollen, dust, irritants such as cigarette smoke, perfumes etc. are some of the substance that triggers the conjunctivitis. Itching is the most typical sign of allergic conjunctivitis, and more than 75 percent of patients report this symptom when seeking treatment. According to Renub Research Allergic Conjunctivitis Market is expected to be more than USD 2 Billion market by 2025.
Global allergic conjunctivitis market will grow due to increasing prevalence of various allergic conjunctivitis, development in medical infrastructure in the developing countries, growing awareness about allergic conjunctivitis among people, increasing ageing population and upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. Allergic conjunctivitis are classified mainly in five types: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) and Giant Papillary Conjunctivitis (GPC).
Request a free sample copy of the report:
https://www.renub.com/contactus.php
Renub Research report titled “Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals, Ocular Therapeutix), Growth Drivers, Challenges” provides a complete analysis of global allergic conjunctivitis market.
China Dominates the Global Allergic Conjunctivitis Patient Population
In this report, we have shown complete insight of country analysis of allergic conjunctivitis patient population. The covered countries are; India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. China dominates the global allergic conjunctivitis patient population numbers.
United States is the leading Country in the Global Allergic Conjunctivitis Market
Allergic conjunctivitis market is growing across all parts of the world. Market growth rates varies in the countries covered in the report India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. United States is leading country in the global allergic conjunctivitis market due to growing awareness, strong healthcare support system and large patient population.
Access full Research: https://www.renub.com/allergic-conjunctivitis-market-p.php
Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Hold Majority of Market in the Global Allergic Conjunctivitis Market
On the basis of disease type, global Allergic conjunctivitis market is further segmented into seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) market, vernal keratoconjunctivitis (VKC) market, atopic keratoconjunctivitis (AKC) market and giant papillary conjunctivitis (GPC) market, globally. Seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) hold majority of market share in the global allergic conjunctivitis market.
Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place
In the global allergic conjunctivitis market, allergic conjunctivitis pipe line drugs will play the major role for the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.
Report has been analyzed from 9 Major Viewpoints
1. Global Allergic Conjunctivitis Market 2. Global Allergic Conjunctivitis Market Share, Disease Type Market Share, Patients Share, Treated Patients Share 3. Country Allergic Conjunctivitis Market 4. Country Allergic Conjunctivitis Patients Population 5. Country Allergic Conjunctivitis Treated Patients Population 6. Disease Type Allergic Conjunctivitis Market 7. Allergic Conjunctivitis Drugs Pipeline8. Growth Drivers and Challenges9. Key Allergic Conjunctivitis Companies Initiatives and Financial Insight
Country Covered – Global Allergic Conjunctivitis Market
• India• China• Japan• United States• United Kingdom• France• Germany• Italy• Spain
Disease Type Covered – Global Allergic Conjunctivitis Market
• Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)• Vernal Keratoconjunctivitis (VKC)• Atopic Keratoconjunctivitis (AKC)• Giant Papillary Conjunctivitis (GPC)
Drugs Profile Covered – Global Allergic Conjunctivitis Market
• Zerviate• OTX-DP• ADX-102• PRT-2761• CVXL-0074• AK-002• Bertilimumab• Reproxalap• ST-266• SYL-116011
Company Covered
• Santen Pharmaceutical• Alcon (Novartis)• Portola Pharmaceuticals• Ocular Therapeutix
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at [email protected]
Browse Related Report :
Epilepsy Drugs Market
Spinal Muscular Atrophy Market
Contact Us
Renub Research
Phone:+1-678-302-0700
Email: [email protected]
Key Topics Covered :
1. Executive Summary
2. Global Allergic Conjunctivitis Market and Patients Analysis
2.1 Allergic Conjunctivitis Market2.2 Allergic Conjunctivitis Patient Numbers2.3 Allergic Conjunctivitis Treated Patient Numbers
3. Share Analysis – Global Allergic Conjunctivitis
3.1 Country Market Share3.2 Patients Population Share3.3 Treated Patients Population Share3.4 By Disease Type Share
4. India
4.1 Allergic Conjunctivitis Patient Numbers4.2 Allergic Conjunctivitis Treated Patient Numbers4.3 Allergic Conjunctivitis Market
5. China
5.1 Allergic Conjunctivitis Patient Numbers5.2 Allergic Conjunctivitis Treated Patient Numbers5.3 Allergic Conjunctivitis Market
6. Japan
6.1 Allergic Conjunctivitis Patient Numbers6.2 Allergic Conjunctivitis Treated Patient Numbers6.3 Allergic Conjunctivitis Market
7. United States
7.1 Allergic Conjunctivitis Patient Numbers7.2 Allergic Conjunctivitis Treated Patient Numbers7.3 Allergic Conjunctivitis Market
8. United Kingdom
8.1 Allergic Conjunctivitis Patient Numbers8.2 Allergic Conjunctivitis Treated Patient Numbers8.3 Allergic Conjunctivitis Market
9. France
9.1 Allergic Conjunctivitis Patient Numbers9.2 Allergic Conjunctivitis Treated Patient Numbers9.3 Allergic Conjunctivitis Market
10. Germany
10.1 Allergic Conjunctivitis Patient Numbers10.2 Allergic Conjunctivitis Treated Patient Numbers10.3 Allergic Conjunctivitis Market
11. Italy
11.1 Allergic Conjunctivitis Patient Numbers11.2 Allergic Conjunctivitis Treated Patient Numbers11.3 Allergic Conjunctivitis Market
12. Spain
12.1 Allergic Conjunctivitis Patient Numbers12.2 Allergic Conjunctivitis Treated Patient Numbers12.3 Allergic Conjunctivitis Market
13. Disease Type – Global Allergic Conjunctivitis Market
13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)13.2 Vernal Keratoconjunctivitis (VKC)13.3 Atopic Keratoconjunctivitis (AKC)13.4 Giant Papillary Conjunctivitis (GPC)
14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs
14.1 Zerviate14.2 OTX-DP (Dexamethasone Insert)14.3 ADX-10214.4 PRT276114.5 CVXL-007414.6 AK-00214.7 Bertilimumab14.8 Reproxalap14.9 ST-26614.10 SYL-116011
15. Growth Driver
15.1 Rapid Urbanization and Growth of Particulate Pollution15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases
16. Challenges
16.1 Diagnostic Challenges16.2 Undertreated by Patients
17. Santen Pharmaceutical
17.1 Company Overview17.2 Initiatives17.3 Financial Insight
18. Alcon Inc. (Novartis)
18.1 Company Overview18.2 Initiatives18.3 Financial Insight
19. Portola Pharmaceuticals Inc.
19.1 Company Overview19.2 Initiatives19.3 Financial Insight
20. Ocular Therapeutix Inc.
20.1 Company Overview20.2 Initiatives20.3 Financial Insight
About Us
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Media ContactCompany Name: Renub ResearchContact Person: Rajat GuptaEmail: Send EmailPhone: 6783020700Address:225 Kristie Ln City: RoswellState: GACountry: United StatesWebsite: www.renub.com/life-science-1-c.php
